Show Summary Details

Quick Reference

n. a gonadotrophin-releasing-hormone antagonist used in the treatment of prostate cancer. It is administered by subcutaneous injection; side-effects include hot flushes and pain at the injection site. Trade name: Firmagon.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.